Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 25 April 2007. doi:10.1136/adc.2006.098442
Archives of Disease in Childhood 2007;92:704-707
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

ORIGINAL ARTICLE

Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?

Iris Treutiger1, Jukka Rajantie2, Bernward Zeller3, Jan-Inge Henter4, Göran Elinder1, Steen Rosthøj5 for the NOPHO ITP Study Group

1 Sachs’ Children’s Hospital, Stockholm, Sweden
2 Paediatric Department, Jorvi Hospital, University of Helsinki, Finland
3 Paediatric Department, Rikshospitalet, Oslo, Norway
4 Childhood Cancer Research Unit, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
5 Paediatric Department, Aalborg Hospital, Denmark

Correspondence to:
Correspondence to:
Dr S Rosthøj
Paediatric Department, Aalborg Hospital, Reberbansgade, 9100 Aalborg, Denmark; steen.rosthoej{at}rn.dk

Aim: To explore whether early treatment of children with idiopathic thrombocytopenic purpura (ITP) with immunoglobulin and/or corticosteroids reduces subsequent morbidity.

Methods: Centres participating in a Nordic ITP study were divided according to whether they had treated more than 2/3, from 1/3 to 2/3, or less than 1/3 children within 14 days of diagnosis. The course of disease from 15 days to 6 months after diagnosis was compared for children managed at the three centre categories. The comparison was restricted to children in whom at least one platelet count <20x109/l was measured, numbering 156, 143 and 84 in the three different categories, respectively.

Results: The three groups of children were clinically similar but were managed with initial treatment rates of 89%, 57% and 14%, respectively. By day 15, the platelet count had stabilised to >20x109/l in 67%, 67% and 52% (p<0.05) and to >150x109/l in 38%, 29% and 29% (p<0.20). At 1 month after diagnosis there was no difference in recovery rates. Chronic ITP developed in 27%, 22% and 25% in the three groups. During follow-up, one or more disease-related events occurred in 23%, 22% and 19%, with no difference in the average numbers of episodes with mucosal bleeding. Treatment courses were administered to 19%, 13% and 11%, respectively.

Conclusion: Active treatment policies accelerated platelet recovery in children with short-lasting ITP but did not avert the development of chronic ITP and did not cause a reduction in morbidity during follow-up.

Abbreviations: CS, corticosteroids; ITP, idiopathic thrombocytopenic purpura; IVIG, intravenous immunoglobulin

Keywords: idiopathic thrombocytopenic purpura; immunoglobulin therapy; corticosteroid therapy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

A brief digest of the August issue
Arch. Dis. Child. 2007 92: e8. [Extract] [Full Text] [PDF]

eLetters:

Read all eLetters

Evidence calls for paradigm shift towards non aggressive approach in immune thrombocytopenic purpura
P Anoop
ADC Online, 24 Jul 2007 [Full text]
Evidence calls for paradigm shift towards non aggressive approach in immune thrombocytopenic purpura
P Anoop
ADC Online, 27 Jul 2007 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs